Macrodantin and Septra drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Macrodantin (nitrofurantoin, macrocrystalline) and Septra (sulfamethoxazole; trimethoprim). Common drug interactions include confusional state among females and abdominal distension among males.

The phase IV clinical study analyzes what interactions people have when they take Macrodantin and Septra. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Macrodantin?

Macrodantin has active ingredients of nitrofurantoin, macrocrystalline. It is often used in urinary tract infection. eHealthMe is studying from 3,755 Macrodantin users. Check the latest studies of Macrodantin.

What is Septra?

Septra has active ingredients of sulfamethoxazole; trimethoprim. It is often used in urinary tract infection. eHealthMe is studying from 10,280 Septra users. Check the latest studies of Septra.



On Apr, 23, 2026

25 people who take Macrodantin and Septra together, and have interactions are studied.

Macrodantin and Septra drug interactions.

What are the common drug interactions of Macrodantin and Septra, by gender? *:

female:

  1. Confusional state
  2. Conjunctivitis (pink eye)
  3. Constipation
  4. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  5. Coronary artery thrombosis (clot formation in coronary artery)
  6. Cough
  7. Cystitis glandularis (forming a timorous lesion with blueberry spots in the urinary bladder)
  8. Deafness
  9. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  10. Drug hypersensitivity

male:

  1. Abdominal distension
  2. Back pain
  3. Nephropathy toxic (damage to kidney due to toxins)
  4. Obstructive uropathy (a blockage that prevents urine from leaving your kidneys)
  5. Oedema (fluid collection in tissue)
  6. Pleural effusion (water on the lungs)
  7. Pulmonary oedema (fluid accumulation in the lungs)
  8. Subclavian artery thrombosis (a condition in which the blood flow through the vessel is obstructed)
  9. Ureteric dilatation
  10. Ureteric obstruction

What are the common drug interactions of Macrodantin and Septra, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Abdominal pain lower
  2. Amenorrhoea (absence of a menstrual period in a woman of reproductive age)
  3. Depression
  4. Dysmenorrhoea (painful menstruation)
  5. Ectopic pregnancy (a pregnancy in which the foetus develops outside the uterus, typically in a fallopian tube)
  6. Haemoperitoneum (presence of blood in the peritoneal cavity)
  7. Impaired healing
  8. Menstruation irregular
  9. Migraine (headache)
  10. Nausea (feeling of having an urge to vomit)

30-39:

n/a

40-49:

  1. Gastritis erosive (a break in the surface layer of the membrane lining the stomach with infection)
  2. Gastroenteritis (inflammation of stomach and intestine)
  3. Gastrointestinal pain
  4. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  5. Haematemesis (vomiting of blood)
  6. Haematuria (presence of blood in urine)
  7. Headache (pain in head)
  8. Heart rate increased
  9. Herpes zoster
  10. Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)

50-59:

  1. Drug hypersensitivity
  2. Pruritus (severe itching of the skin)

60+:

  1. Abdominal discomfort
  2. Arrhythmia (irregular heartbeat)
  3. Weight decreased
  4. Asthenia (weakness)
  5. International normalised ratio increased
  6. Anaemia (lack of blood)
  7. Atrophy (wasting away of a part of the body)
  8. Haematuria (presence of blood in urine)
  9. Activated partial thromboplastin time prolonged
  10. Contusion (a type of hematoma of tissue in which capillaries)

What are the existing conditions these people have? *

  1. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 6 people, 24.00%

* Approximation only. Some reports may have incomplete information.

Do you take Macrodantin and Septra?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Macrodantin and Septra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Macrodantin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Septra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Macrodantin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Septra and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on nitrofurantoin, macrocrystalline and sulfamethoxazole; trimethoprim (the active ingredients of Macrodantin and Septra, respectively), and Macrodantin and Septra (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: